Rothschild & Co Redburn Downgrades Insulet Corporation (PODD) Due to Eroding Product Moats
On April 24, Rothschild & Co Redburn downgraded Insulet Corporation (NASDAQ:PODD) from Buy to Neutral and lowered its price target to $220 from $380. The firm cited eroding product moats and distribution challenges as key concerns affecting the company's ability to sustain a premium valuation.
Tickers: $PODD
Topics: Analyst Downgrade Insulet Corporation Medical Devices Stock Rating Changes